XML 30 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Various Stock Compensation Plans And Agreements
Stock Repurchase Plan
Common Stock
Common Stock
Various Stock Compensation Plans And Agreements
Common Stock
Stock Repurchase Plan
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Treasury Stock
Various Stock Compensation Plans And Agreements
Treasury Stock
Stock Repurchase Plan
AOCI, Net of Tax
Beginning balance (in shares) at Dec. 31, 2021         141,907,954                  
Beginning balance at Dec. 31, 2021 $ 5,837,218             $ 1,893,725 $ 4,683,659   $ (649,785)     $ (90,381)
Increase (Decrease) in Stockholders' Equity                            
Net income 1,128,083               1,128,083          
Other comprehensive income (loss) (675,248)                         (675,248)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         671,871                  
Issuance of common stock pursuant to various stock compensation plans and agreements 42,832             42,832            
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements (in shares)           (246,462) (1,385,517)              
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements     $ (19,087) $ (99,990)               $ (19,087) $ (99,990)  
Cash dividends on common stock (229,196)               (229,196)          
Ending balance (in shares) at Dec. 31, 2022         140,947,846                  
Ending balance at Dec. 31, 2022 5,984,612 $ (4,262) [1]           1,936,557 5,582,546 $ (4,262) [1] (768,862)     (765,629)
Increase (Decrease) in Stockholders' Equity                            
Net income 1,161,161               1,161,161          
Other comprehensive income (loss) 145,033                         145,033
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         913,185                  
Issuance of common stock pursuant to various stock compensation plans and agreements 44,430             44,430            
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements (in shares)           (327,573) (1,506,091)              
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements     (23,751) (82,174)               (23,751) (82,174)  
Cash dividends on common stock (274,215)               (274,215)          
Ending balance (in shares) at Dec. 31, 2023         140,027,367                  
Ending balance at Dec. 31, 2023 6,950,834 $ (9,482) [2]           1,980,987 6,465,230 $ (9,482) [2] (874,787)     (620,596)
Increase (Decrease) in Stockholders' Equity                            
Net income 1,165,586               1,165,586          
Other comprehensive income (loss) 35,336                         35,336
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         553,149                  
Issuance of common stock pursuant to various stock compensation plans and agreements 49,895             49,895            
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements (in shares)           (199,871) (1,943,346)              
Repurchase of common stock pursuant to the stock repurchase program/various stock compensation plans and agreements     $ (14,877) $ (144,446)               $ (14,877) $ (144,446)  
Cash dividends on common stock (309,792)               (309,792)          
Ending balance (in shares) at Dec. 31, 2024         138,437,299                  
Ending balance at Dec. 31, 2024 $ 7,723,054             $ 2,030,882 $ 7,311,542   $ (1,034,110)     $ (585,260)
[1] Represents the change in the Company’s allowance for loan losses as a result of the adoption of Accounting Standards Update (“ASU”) 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and the Vintage Disclosures on January 1, 2023.
[2] Represents the impact of the adoption of ASU 2023-02, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method on January 1, 2024. Refer to Note 1 — Summary of Significant Accounting Policies to the Consolidated Financial Statements in this Annual Report on Form 10-K (“this Form 10-K”) for additional information.